Telepsychiatry COVID-19 Webcast Series: Special Practices and Considerations for the Initiation and Continuation of Care in Patients with Substance Use Disorders (i.e., Opioids and Alcohol)

Thursday, August 13, 2020, 8:00 AM - Friday, August 20, 2021, 11:59 AM


AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)

Telepsychiatry COVID-19 Webcast Series: Special Practices and Considerations for the Initiation and Continuation of Care in Patients with Substance Use Disorders (i.e., Opioids and Alcohol)
(Live presentation held on August 12, 2020)

In the midst of the COVID pandemic, telepsychiatry has taken a prominent role in providing continued care for patients. This special summer series of five lectures will cover the best practices, legal and ethical of telepsychiatry. It will also address the use of telepsychiatry and special considerations for specific psychiatric conditions including bipolar disorder, schizophrenia and substance use disorders.

This presentation is the fifth lecture of a five lecture series. For a list of the remaining lectures, visit the brochure tab.

For more information about this series, contact Marcelle Shidler.

1. Describe the context, history and trends impacting Telepsychiatry in addiction treatment;
2. Adapt telepsychiatry treatments to addiction services;
3. Describe best clinical practice for conducting addiction treatment with individual patients.

This series is offered at no cost.

To receive credit, you must complete the following:

• Review CME Front Matter below;
• Review speaker conflict of interest disclosures (or lack of conflict of interest) in the Faculty Tab;
• Complete the pre-test;
• View content in its entirety;
• Successfully complete the post-test (75%);
• Complete evaluation to retrieve the certificate. Evaluations are located in the 'My CME' section of your user account.

For State of Ohio Counselor and Social Worker Board & Ohio Psychological Association Only. 
If you are a licensed social worker/counselor, a nurse, or a member of the Ohio Psychological Association, please provide your credentials on your submitted evaluations. Learners must send a copy of the certificate of completion to Marcelle Shidler at marcelle.shidler@uc.edu. 

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Ohio Psychological Association
The University of Cincinnati is accredited by the Ohio Psychological Association and designates this distance learning activity for a maximum of 1.0 OPA-MCE credit hour per Grand Rounds presentation.

State of Ohio Counselor and Social Worker Board
The University of Cincinnati is accredited by the State of Ohio Counselor and Social Worker Board and designates this distance learning activity for a maximum of 1.0 clock hour CEU per Grand Rounds presentation.

This presentation is the fifth lecture of a five lecture series. For a list of the remaining lectures, visit the brochure tab.

CME FRONT MATTER

Faculty Disclosures / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Cincinnati College of Medicine has a conflict of interest policy that requires, all faculty, planning committee members, and other individuals who are in a position to control content, to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosure will be made at the time of activity.

The following disclosures were made:

• Caleb Adler, MD - (Speaker's Bureau) Janssen, and Otsuka
• Henry A. Nasarallah, MD - (Consultant/Advisory Board/Speaker) Acadia, Alkermes, Allergan, Indivior, Intracellular, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, and Teva; Advisory Board/Consultant) Boehringer-Ingelheim, and Esai
• Fabiano Nery, MD - Spouse is an employee/stockholder of Eli Lilly
  

All other planning committee members, peer/content reviewers, and CME staff have no relevant conflict of interest to report.

Disclaimer Statement
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees professional development.

Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

This CME lecture series are funded by a generous unrestricted educational grant from Alkermes, Inc.